4.5 Article

DNA Methylation and Transcription of HLA-F and Serum Cytokines Relate to Chinese Medicine Syndrome Classification in Patients with Chronic Hepatitis B

Journal

CHINESE JOURNAL OF INTEGRATIVE MEDICINE
Volume 28, Issue 6, Pages 501-508

Publisher

SPRINGER
DOI: 10.1007/s11655-021-3279-8

Keywords

cytokine; chronic hepatitis B; DNA methylation; human leukocyte antigen F; Chinese medicine syndrome

Funding

  1. Key Program of National Natural Science Foundation of China [81330084]
  2. National Science and Technology Major Special Project [2012ZX10005001-004]
  3. National Key Research and Development: Special Project for Research on the Modernization of Traditional Chinese Medicine [2018YFC1704204]
  4. Science and Technology Commission of Shanghai Municipality [19YF1449900]

Ask authors/readers for more resources

This study aimed to investigate the molecular basis of Chinese medicine syndrome classification in chronic hepatitis B patients in terms of DNA methylation, transcription, and cytokines. The results suggest that demethylation of CpG loci in the HLA-F gene's 5' UTR region may up-regulate its mRNA expression, and HLA-F expression is associated with IL-12, MIP-1 alpha, and MIP-1 beta levels.
Objective To explore the molecular bases of Chinese medicine (CM) syndrome classification in chronic hepatitis B (CHB) patients in terms of DNA methylation, transcription and cytokines. Methods Genome-wide DNA methylation and 48 serum cytokines were detected in CHB patients (DNA methylation: 15 cases; serum cytokines: 62 cases) with different CM syndromes, including dampness and heat of Gan (Liver) and gallbladder (CHB1, DNA methylation: 5 cases, serum cytokines: 15 cases), Gan stagnation and Pi (Spleen) deficiency (CHB2, DNA methylation: 5 cases, serum cytokines: 15 cases), Gan and Shen (Kidney) yin deficiency (CHB3, DNA methylation: 5 cases, serum cytokines: 16 cases), CHB with hidden symptoms (HS, serum cytokines:16 cases) and healthy controls (DNA methylation: 6 cases). DNA methylation of a critical gene was further validated and its mRNA expression was detected on enlarged samples. Genome-wide DNA methylation was detected using Human Methylation 450K Assay and furthered verified using pyrosequencing. Cytokines and mRNA expression of gene were evaluated using multiplex biometric enzyme-linked immunosorbent assay (ELISA)-based immunoassay and reverse transcription-quantitative polymerase chain reaction (RT-qPCR), respectively. Results Totally 28,667 loci, covering 18,403 genes were differently methylated among CHB1, CHB2 and CHB3 (P 0.17). Further validation showed that compared with HS, the hg19 CHR6: 29691140 and its closely surrounded 2 CpG loci were demethylated and its mRNA expressions were significantly up-regulated in CHB1 (P<0.05). However, they remained unaltered in CHB2 (P>0.05). Levels of Interleukin (IL)-12 were higher in CHB3 and HS than that in CHB1 and CHB2 groups (P<0.05). Levels of macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta were higher in CHB3 than other groups and leukemia inhibitory factor level was higher in CHB1 and HS than CHB2 and CHB3 groups (P<0.05). IL-12, MIP-1 alpha and MIP-1 beta concentrations were positively correlated with human leukocyte antigen F (HLA-F) mRNA expression (R-2=0.238, P<0.05; R-2=0.224, PR=0.447, P<0.01; respectively). Furthermore, combination of HLA-F mRNA and differential cytokines greatly improved the differentiating accuracy among CHB1, CHB2 and HS. Conclusions Demethylation of CpG loci in 5 ' UTR of HLA-F may up-regulate its mRNA expression and HLA-F expression was associated with IL-12, MIP-1 alpha and MIP-1 beta levels, indicating that HLA-F and the differential cytokines might jointly involve in the classification of CM syndromes in CHB. Registration No. ChiCTR-RCS-13004001.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available